GDTC NASDAQ
CytoMed Therapeutics Limited
1W: -7.8%
1M: +0.0%
3M: -9.3%
YTD: -36.7%
1Y: -56.2%
3Y: -74.2%
$0.92
+0.02 (+2.23%)
Weekly Expected Move ±12.4%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$7M
-21.3% ▼
5Y CAGR: +27.7%
Total Liabilities
$750K
-12.0% ▼
5Y CAGR: +0.2%
Shareholders Equity
$7M
-23.0% ▼
5Y CAGR: +35.7%
Cash & Investments
$4M
-46.6% ▼
5Y CAGR: +60.8%
Total Debt
$339K
-0.1% ▼
5Y CAGR: -7.4%
Net Debt
-$3M
+49.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $670K | $2M | $1M | $7M | $4M |
| Short-Term Investments | $33K | $11K | $0 | $0 | $0 |
| Cash & ST Investments | $703K | $2M | $1M | $7M | $4M |
| Net Receivables | $0 | $0 | $0 | $0 | $14K |
| Inventory | $182K | $320K | $430K | $514K | $614K |
| Other Current Assets | $197K | $137K | $219K | $200K | $97K |
| Total Current Assets | $1M | $2M | $2M | $8M | $4M |
| Property, Plant & Equip. | $2M | $2M | $2M | $2M | $2M |
| Goodwill & Intangibles | $34K | $24K | $14K | $9K | $68K |
| Long-Term Investments | $0 | $202K | $179K | $148K | $162K |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $366K |
| Total Non-Current Assets | $2M | $2M | $2M | $2M | $3M |
| Total Assets | $3M | $5M | $4M | $9M | $7M |
| — Liabilities — | |||||
| Accounts Payable | $14K | $34K | $11K | $19K | $28K |
| Short-Term Debt | $2M | $2M | $3M | $26K | $28K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $40K | $30K | $127K | $156K | $116K |
| Total Current Liabilities | $2M | $2M | $3M | $543K | $444K |
| Long-Term Debt | $447K | $400K | $350K | $309K | $289K |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $465K | $411K | $355K | $309K | $306K |
| Total Liabilities | $3M | $3M | $3M | $852K | $750K |
| — Equity — | |||||
| Common Stock | $3M | $5M | $7M | $18M | $17M |
| Retained Earnings | -$2M | -$4M | -$6M | -$9M | -$11M |
| Accumulated OCI | -$6K | $823K | -$95K | -$109K | $15K |
| Total Stockholders Equity | $360K | $2M | $438K | $9M | $7M |
| Total Liabilities & Equity | $3M | $5M | $4M | $9M | $7M |
| — Key Metrics — | |||||
| Total Debt | $2M | $2M | $3M | $339K | $339K |
| Net Debt | $2M | $553K | $2M | -$6M | -$3M |
| Total Investments | $33K | $214K | $179K | $148K | $162K |